[163] There was low- to moderate-strength evidence of no benefit for most of the other medications used in RCTs, which included antidepressants (bupropion, mirtazapine, sertraline), antipsychotics (aripiprazole), anticonvulsants (topiramate, baclofen, gabapentin), naltrexone, varenicline, citicoline, ondansetron, prometa, riluzole, atomoxetine, dextroamphetamine, and modafinil
Oxidative stress in age-related macular degeneration: Nrf2 as therapeutic target
3 Based on our promising preliminary results, we are planning to recruit more patients to confirm our findings regarding GSH increase and improved seizure control
5-Amino-1MQ might be one such underutilized tool
,
Garolla, A., et al